Algorithm for Diagnosis and Treatment of Malaria in the United States*
CDC Malaria Hotline: (770) 488-7788 or (855) 856-4713 (toll free), Monday–Friday, 9 am–5 pm EST;
(770) 488-7100 after hours, weekends, and holidays
Fever and history of travel to malaria-endemic
area, or clinical suspicion of malaria
Evaluation
Disposition
Perform thick and thin blood smears
and read on the same day**
Medication
No Blood smear Yes
positive?
Repeat blood smears every
12–24 hours From smear: calculate parasite density
(total of 3 times) and determine species
No Blood smear Yes
positive? Evaluate clinical status and
disease severity
Consider alternate
diagnosis Uncomplicated Severe malaria and/or patient
malaria unable to tolerate oral
medication, regardless of species†
P. falciparum, P. knowlesi, P. ovale or P. vivax acquired in P. vivax
P. malariae area without chloroquine acquired in area Admit to intensive care unit
or species not yet
identified† resistance with Call CDC
chloroquine
resistance
Admit to hospital and monitor
for disease progression Chloroquine or Chloroquine or Intravenous artesunate
Hydroxychloroquine‡ Hydroxychloroquine‡
If needed, interim treatment:
P. falciparum or species Artemether-lumefantrine
not yet identified† or
Artemether-lumefantrine Atovaquone-proguanil
P. knowlesi or or
Atovaquone-proguanil Quinine
or or, if no other options,
Quinine plus tetracycline Mefloquine
Chloroquine or or doxycycline or
Hydroxychloroquine‡ clindamycin
or, if no other options,
Mefloquine
P. falciparum Monitor parasite density
P. falciparum acquired P. falciparum every 12–24 hours
acquired in area with
in area with acquired in area with
no chloroquine
chloroquine resistance mefloquine resistance
resistance PLUS
Artemether-lumefantrine Artemether-lumefantrine If not G6PD deficient by Administer follow on treatment
(preferred) (preferred) quantitative testing: after intravenous artesunate:†
Chloroquine or
or or Artemether-lumefantrine
Hydroxychloroquine‡ Primaquine (any prior regimen
Atovaquone-proguanil Atovaquone-proguanil for acute infection) or or
or or Tafenoquine (only if Atovaquone-proguanil
Quinine plus tetracycline Quinine plus tetracycline chloroquine used for acute or
or doxycycline or or doxycycline or infection; not for children <16 Quinine and doxycycline (or
clindamycin clindamycin years old) clindamycin)
or, if no other options, or, if no other options,
Mefloquine Mefloquine
Footnotes:
* Treatment for special populations (children and pregnant women) can be found in the CDC Treatment Guidelines and
Treatment Table.
** If rapid diagnostic test performed, smear should also be performed with results available as soon as possible.
† If species later identified as P. vivax or P. ovale, add primaquine if not G6PD deficient by quantitative testing. Tafenoquine can
only be used if chloroquine or hydroxychloroquine used for acute infection.
‡Drug options for chloroquine-resistant P. falciparum may be used.